NDC properties for NDC 9 72606-040
NDC item 72606004001
| NDC 9 | 72606-040 |
|---|---|
| NDC 10 | 72606-040-01 |
| NDC Item | 72606004001 |
| packaging | 1 SYRINGE, GLASS in 1 CARTON (72606-040-01) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
NDC item 72606004002
| NDC 9 | 72606-040 |
|---|---|
| NDC 10 | 72606-040-02 |
| NDC Item | 72606004002 |
| packaging | 1 SYRINGE, GLASS in 1 CARTON (72606-040-02) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |
NDC item 72606004003
| NDC 9 | 72606-040 |
|---|---|
| NDC 10 | 72606-040-03 |
| NDC Item | 72606004003 |
| packaging | 2 SYRINGE, GLASS in 1 CARTON (72606-040-03) / .8 mL in 1 SYRINGE, GLASS |
| BLA | BLA761219 |
| FDA SPL set id | 753287 |
| Labeler | CELLTRION USA, Inc. |
| Label type | HUMAN PRESCRIPTION DRUG |
| Marketing category | BLA |
| Marketing effective time low | 2023-11-30 |
| Marketing status | ACTIVE |